人FKBP52的基因克隆、表达及活性研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家“973”创新药物基金资助项目(G1998051107).


The Gene Cloning, Expression and Bioactivity of the Human FKBP52
Author:
Affiliation:

Fund Project:

This work was supported by the Ministry Science and Technology of China(G1998051107).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为获得具有生物学活性的hFKBP52,来筛选新型的促神经再生药物.采用半巢式、桥联PCR及亲和层析方法,从人胎脑cDNA文库中成功扩增出hFKBP52基因,在pET28a(+)中实现了高效、可溶性的融合表达,表达量约30%.重组的蛋白质经亲和纯化至电泳纯,纯化后的hFKBP52显示出肽基脯氨基顺反异构酶活性.表明原核表达的hFKBP52具有类似于其天然蛋白质的生物学活性.

    Abstract:

    To obtain active hFKBP52 protein for screening novel neurotrophic drugs. Semi-nested and overlap PCR and affinity chromatography were used. hFKBP52 gene was cloned successfully from human fetal brain cDNA library, and then highly expressed (about 30%) as fusion protein in pET28a(+) vector system. The recombinant protein was purified as one band on SDS-PAGE. The purified hFKBP52 showed peptidyl-prolyl cis-trans isomerase (PPIase) activity, similar to the wild type.

    参考文献
    相似文献
    引证文献
引用本文

裴武红,贺永怀,陈兴,李松,沈倍奋.人FKBP52的基因克隆、表达及活性研究[J].生物化学与生物物理进展,2001,28(2):236-239

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2000-04-17
  • 最后修改日期:2000-06-19
  • 接受日期:
  • 在线发布日期:
  • 出版日期: